Search for
Creatine Kinase-MB (CK-MB)
Heart
Report in 4Hrs
At Home
No Fasting Required
Details
CK-MB is an isoenzyme of Creatine Kinase (CK) that is primarily found in the heart muscle. It is released into the bloodstream when heart muscle cells are damaged
₹299₹715
58% OFF
Creatine Kinase-MB (CK-MB) Test Guide
- Why is it done?
- Test Purpose: CK-MB measures the cardiac muscle isoenzyme of creatine kinase to detect cardiac muscle damage or myocardial infarction (heart attack)
- Primary Indications: Evaluation of acute chest pain or suspected acute coronary syndrome; assessment of myocardial infarction; monitoring cardiac complications following cardiac surgery or coronary intervention; evaluation of heart failure or cardiac injury
- Typical Timing: Ordered in emergency departments during acute chest pain presentation; typically collected at admission and repeated at 3-hour intervals; most useful 12-48 hours after symptom onset
- Clinical Applications: Rule out myocardial infarction; estimate timing of cardiac damage; assess severity of heart attack; monitor recovery following cardiac procedures; evaluate traumatic cardiac injury
- Normal Range
- Reference Ranges: 0-5 ng/mL or 0-12 IU/L (ranges vary by laboratory); some labs use <5% of total CK as normal threshold
- Units of Measurement: nanograms per milliliter (ng/mL) or International Units per liter (IU/L); can also be expressed as CK-MB/Total CK ratio
- Normal Results: Indicate absence of acute myocardial infarction or significant cardiac muscle damage at time of testing; does not completely exclude cardiac events if tested too early
- Elevated Results: CK-MB >5 ng/mL or >12 IU/L suggests cardiac muscle damage; highly specific for myocardial infarction when elevated with compatible clinical presentation
- Borderline Values: Levels between 2-5 ng/mL may require serial testing and clinical correlation; trending results over time more useful than single value
- Interpretation
- Elevated CK-MB Interpretation: Most specific marker for acute myocardial infarction; elevation typically begins 3-6 hours after symptom onset, peaks at 24-36 hours, and normalizes within 3-4 days
- CK-MB/Total CK Ratio: Ratio >2-3% suggests cardiac source; helps differentiate cardiac from skeletal muscle origin of elevated total CK
- Serial Testing Patterns: Rising levels with each collection strongly suggests acute MI; peak height correlates with infarct size; persistent elevation suggests ongoing cardiac damage
- Factors Affecting Interpretation: Timing of blood draw relative to symptom onset; skeletal muscle injury may elevate total CK but not CK-MB; renal disease affects clearance; recent cardiac surgery; muscle disorders or trauma
- Clinical Significance of Patterns: Single normal CK-MB does not exclude MI; negative serial results at 0, 3, and 6 hours have high negative predictive value; elevated CK-MB with low total CK is more specific for cardiac origin
- Limitations: Can be detected in small amounts in skeletal muscle; less sensitive for detecting reinfarction; now often supplemented or replaced by high-sensitivity troponin assays
- Associated Organs
- Primary Organ System: Cardiovascular system, specifically cardiac muscle (myocardium); CK-MB is predominantly found in heart tissue
- Conditions Associated with Elevated CK-MB: Acute myocardial infarction (STEMI or NSTEMI); unstable angina with cardiac necrosis; cardiac trauma or contusion; myocarditis; heart failure with acute decompensation; cardiac arrhythmias with hemodynamic compromise; acute pulmonary embolism with right heart strain
- Other Associated Conditions: Sepsis with cardiac involvement; severe shock or hypoxemia; cardiac surgery complications; cardioversion or defibrillation; electrical injury affecting the heart; pericarditis with myocardial involvement
- Complications of Abnormal Results: Myocardial infarction may lead to ventricular dysfunction, cardiogenic shock, arrhythmias, heart failure, or sudden cardiac death if not treated promptly
- Prognosis Correlation: Higher CK-MB levels generally correlate with larger infarct size and potentially worse prognosis; markedly elevated levels may indicate extensive myocardial necrosis
- Follow-up Tests
- Recommended Follow-up Tests: High-sensitivity troponin (cTnI or cTnT) - more sensitive and specific cardiac marker; troponin T or I for confirmatory testing; myoglobin for additional MI confirmation
- Complementary Diagnostic Tests: Electrocardiogram (ECG) for wall motion abnormalities; cardiac imaging (echocardiogram, cardiac MRI, or CT angiography); coronary angiography for intervention assessment
- Additional Cardiac Biomarkers: B-type natriuretic peptide (BNP) for heart failure assessment; C-reactive protein (CRP) for inflammation; lactate dehydrogenase (LDH); complete metabolic panel
- Serial Testing Protocol: Repeat CK-MB every 3 hours for first 12 hours if initial result negative and clinical suspicion remains high; serial troponin testing now preferred at 0, 3, and 6 hours
- Monitoring After Diagnosis: Daily testing if MI confirmed; continued ECG monitoring; echocardiography to assess ventricular function; stress testing or imaging for ischemia assessment post-recovery
- Long-term Follow-up: Lipid panel for risk factor management; blood pressure monitoring; diabetes screening; repeat imaging for residual ischemia or ejection fraction assessment
- Fasting Required?
- Fasting Requirement: No - fasting is NOT required for CK-MB testing
- Patient Preparation: Can eat and drink normally; no dietary restrictions; routine activities permitted prior to testing
- Medication Considerations: Continue all regular medications unless specifically instructed otherwise by physician; cardiac medications should be continued as prescribed
- Activity Restrictions: Avoid strenuous exercise or intense physical activity immediately before testing; rest for 5-10 minutes before blood draw to ensure stable vital signs
- Urgent/Emergency Situations: In acute chest pain or MI protocol, testing proceeds immediately regardless of fasting status; no delay for preparation is appropriate
- Sample Collection: Standard blood draw procedure; venipuncture required; collected in serum separator tube; processed at laboratory within specified timeframe
How our test process works!
